- Karachi Tax Bar Association (KTBA) highlights tax challenges faced by Pakistan’s pharmaceutical sector
- Concerns raised about recent changes in sales tax regulations
- New provision under Rule 18A of Sales Tax Rules excludes certain registered entities from following specific rules
- Pharmaceutical sector subjected to fixed 1% sales tax rate without input tax claim
- KTBA requests FBR to extend provisions of Rule 18A to include pharmaceutical sector
- Call for clarity and fairness in application of sales tax laws
- Hope for favorable resolution to address tax concerns in pharmaceutical sector
Source: pkrevenue.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
